Elixirr International plc (LSE:ELIX) saw its shares climb more than 4% on Monday after reporting exceptional revenue growth in the first half of 2025, setting new records for both quarters ending June 30.

The consulting firm, which recently transitioned to the London Stock Exchange’s Main Market, revealed a 35% increase in revenue year-over-year for the six-month period. Organic growth accounted for a 17% rise compared to the same timeframe in 2024. Profit margins remained stable, consistent with recent performance.

Earlier, Elixirr had announced record revenue for Q1 2025, and Monday’s update confirmed the second quarter continued that momentum, featuring five record-breaking months.

The company’s board expressed confidence that full-year results will meet market expectations. Interim financial results for the half-year ending June 30 are scheduled for release on September 22.

Founder and CEO Stephen Newton stated, “We are pleased to report continued growth in H1 25, maintaining our track record of profitable growth since our AIM IPO,”

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.